Neoadjuvant immunochemotherapy for resectable esophageal cancer: A study on efficacy and safety. Biomol Biomed [Internet]. 2025 Aug. 5 [cited 2025 Aug. 28];25(9):2127–2138. Available from: https://www.bjbms.org/ojs/index.php/bjbms/article/view/11806